Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MCKESSON CORP Board/Management Information 2012

Apr 5, 2012

29879_rns_2012-04-05_944c8ced-1a9f-421d-9054-0c62bee628c6.zip

Board/Management Information

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 31, 2012

McKesson Corporation

(Exact name of registrant as specified in its charter)

Delaware 1-13252 94-3207296
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
One Post Street, San Francisco, California 94104
(Address of principal executive offices) (Zip Code)

(415) 983-8300

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective March 31, 2012, Marc E. Owen resigned as executive vice president, corporate strategy and business development, of McKesson Corporation (the “Company”). Mr. Owen was identified as a “named executive officer” in the Company’s 2011 definitive proxy statement, which was filed with the Securities and Exchange Commission on June 20, 2011. While he no longer serves as an executive officer, Mr. Owen will continue to serve the Company as president of McKesson Specialty Health, a position he has held since January 31, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 5, 2012

McKesson Corporation
By: /s/ Laureen E. Seeger
Laureen E. Seeger
Executive Vice President, General Counsel and Chief Compliance Officer